Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0281182 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Thomas G Biel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of Am…. Hauptthemen laut MEDLINE: Adenocarcinoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NCI NIH HHS, NHGRI NIH HHS, United States Food and Drug Administration.
Abstract (Originalsprache)
In pancreatic cancer clinical trials, Black patients are under-represented while having higher morbidity and mortality rates as compared to other racial groups. Multiple factors, including socioeconomic and lifestyle factors may contribute to this disparity, but genomic contributions remain unclear. In an exploratory project to identify genes that may contribute to differences in survival between Black (n = 8) and White (n = 20) patients with pancreatic cancer, transcriptomic sequencing of over 24,900 genes was performed in human pancreatic tumor and non-tumor tissue obtained from Black and White patients. Over 4,400 genes were differentially expressed in tumor and non-tumor tissue, irrespective of race. To validate these results, the expression of four genes (AGR2, POSTN, TFF1, and CP) reported to be up-regulated in pancreatic tumor tissue as compared to non-tumor tissue were confirmed using quantitative PCR. Transcriptomic analysis that compared pancreatic tumor tissue from Black and White patients revealed differential expression in 1,200 genes, while a comparison of the non-tumor and tumor gene expression differences within each race revealed over 1,500 tumor-specific differentially expressed genes in pancreatic tumor and non-tumor tissue from Black patients. We identified TSPAN8 as a potential tumor-specific gene significantly overexpressed in pancreatic tumor tissue in Black patients as compared to White patients. Using Ingenuity Pathway Analysis software to compare the race-associated gene expression profiles, over 40 canonical pathways were identified to be potentially impacted by the gene expression differences between the races. Heightened expression of TSPAN8 was associated with poor overall survival, suggesting TSPAN8 as one potential genetic factor contributing to the differential outcomes in Black patients with pancreatic cancer, supporting the potential utility of larger genomic studies to further explore the role of TSPAN8 in pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
- Office of Oncologic Diseases, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
- Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
ORCID-Profile: Kelly M Herremans, Andrea N Riner, Patrick W Underwood, Michael H Gerber, V Ashutosh Rao
Förderung
- NCI NIH HHS
- NHGRI NIH HHS
- United States Food and Drug Administration
- National Human Genome Research Institute
- National Cancer Institute
- National Institutes of Health and the Joseph and Ann Matella Fund for Pancreatic Cancer Research
Zitieren
APA
Biel, T. G., Petrovskaya, S., Mascia, F., Ju, T., Fashoyin-Aje, L., Herremans, K. M., Riner, A. N., Underwood, P. W., Gerber, M. H., Donoghue, M., Trevino, J. G., & Rao, V. A. (2023). Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0281182
Vancouver
Biel TG, Petrovskaya S, Mascia F, Ju T, Fashoyin-Aje L, Herremans KM, et al. Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients. PLOS ONE. 2023. doi:10.1371/journal.pone.0281182
BibTeX
@article{Biel2023,
author = {Biel, Thomas G and Petrovskaya, Svetlana and Mascia, Francesca and Ju, Tongzhong and Fashoyin-Aje, Lola and Herremans, Kelly M and Riner, Andrea N and Underwood, Patrick W and Gerber, Michael H and Donoghue, Martha and Trevino, Jose G and Rao, V Ashutosh},
title = {Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0281182}
}
EUVIMED